Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Tuberculosis Drugs market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 
Report Description
Tuberculosis is a deadly infectious disease that affects the lungs. Among diseases, tuberculosis is the second largest cause of death worldwide. Tuberculosis are broadly classified as latent tuberculosis and active tuberculosis. Globally around 10% of latent infections develop into active tuberculosis. Infections that do not show any symptoms are called latent tuberculosis. In 2015, the malady resulted in 1.8 million deaths and 10.4 million new reported cases. In 2015, in the U.S., there were 9,557 tuberculosis cases reported. Based on the statistics of Center for Disease Control and Prevention, a 1.6% increase in the number of tuberculosis cases was observed in 2015 as compared to those reported in 2014. Though there is an increase in the number of tuberculosis cases, the incidence rate per 100,000 persons has been around 3.0 since 2013.
Market Dynamics
Asia and Africa are the largest markets for tuberculosis drugs, as these regions have the highest prevalence of TB. There are many initiatives taken to control the TB increasing cases. The United Nations' Millennium Development Goals have framed various strategies to reduce TB prevalence and death rates by 2015, which can be achieved by WHO's Stop TB Strategy. According World Health Organization, in 2006, 61% out of 2.5 million new smear positive cases with DOTS, and are all the new smear cases on the year, and the treatment was successful in 85% cases. The estimated global incidence rate of tuberculosis shown decline rate by 0.6% in 2005 and 2006. In 2006, the incidence rate of tuberculosis became stable in the Europe and is declining gradually in the other WHO countries. World Health Organization has an approximation that the occurrence of tuberculosis and death rates are declining faster than the incidence rate.
Market Taxonomy
This report segments the global tuberculosis drugs market on the basis of therapy type and geography. On the basis of therapy type, the market is categorized into first line drugs, Second line drugs and combination drug therapy. Under First line drugs, the market is further segmented into drugs such as Isoninazid, Rifampicin, Ethambutol, Pryazinamide, and Strepromycin. The second line drugs are further segmented into Injectable, Fluoroquinolones, and Bacteriostatic Agents and Others. For comprehensive understanding of market dynamics, the global tuberculosis drugs market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
• This report provides in-depth analysis of the tuberculosis drugs market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global tuberculosis drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Pfizer Inc, Lupin Laboratories Ltd, AstraZeneca Plc, Cadila Pharmaceuticals, Novartis AG, Alkem Laboratories Ltd, and Cipla Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
• The global tuberculosis drugs market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers for tuberculosis drugs, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the tuberculosis drugs market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global Tuberculosis Drugs Market, By Therapy Type:
o First Line Drugs Therapy
o Second Line Drugs Therapy
o Combination Drugs Therapy
• Global Healthcare Biometrics Market, By Geography:
o North America
 U.S.
 U.S. Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Canada
 Canada Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
o Europe
 U.K.
 U.K. Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Germany
 Germany Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Italy
 Italy Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 France
 France Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Spain
 Spain Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Russia
 Russia Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Rest of Europe
 Rest of Europe Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
o Asia-Pacific
 China
 China Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 India
 India Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Japan
 Japan Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 ASEAN
 ASEAN Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Australia
 Australia Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 South Korea
 South Korea Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Rest of Asia Pacific
 Rest of Asia Pacific Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
o Latin America
 Brazil
 Brazil Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Mexico
 Mexico Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Rest of Latin America
 Rest of Latin America Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
o Middle East
 GCC
 GCC Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Israel
 Israel Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Rest of Middle East
 Rest of Middle East Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
o Africa
 North Africa
 North Africa Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 Central Africa
 Central Africa Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
 South Africa
 South Africa Tuberculosis Drug Market, By Therapy Type:
 First Line Drugs Therapy
 Second Line Drugs Therapy
 Combination Drugs Therapy
• Company Profiles
o Pfizer Inc *
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Lupin Laboratories Ltd
o AstraZeneca Plc
o Cadila Pharmaceuticals
o Novartis AG
o Alkem Laboratories Ltd
o Cipla Ltd.
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Therapy Type
? Market Snippet By Geography
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Pricing Scenario
o PEST Analysis
o Campaigns and Programs
o Distribution Channel
o Pipeline Drugs
o Prevalence and Incidence
4. Global Tuberculosis Drugs Market, By Therapy Type, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o First Line Drugs Therapy
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
? Segment Trend
? Isoniazid
? Rifampicin
? Ethambutol
? Pyrazinamide
? Streptomycin
o Second Line Drugs Therapy
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
? Segment Trend
? Injections
? Fluoroquinolones
? Bacteriostatic Agents
? Others
o Combination Drug Therapy
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
5. Global Tuberculosis Drugs Market, By Geography, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, For Regions, 2014 - 2024
o North America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Canada
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
o Europe
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Germany
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Italy
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? France
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Spain
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Russia
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Rest of Europe
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
o Asia Pacific
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? India
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Japan
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Australia
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Rest of Asia Pacific
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
o Latin America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Argentina
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Rest of Latin America
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
o Middle East
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Israel
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Rest of Middle East
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
o Africa
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Therapy Type, 2014 - 2024 (US$ Million)
6. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Pfizer, Inc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Lupin Laboratories Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Astrazeneca plc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Cadila Pharmaceuticals Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Alkem Laboratories
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Cipla Ltd
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
7. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 22 market data tables and 44 figures on "Tuberculosis Drugs - Global forecast to 2024".
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us